HUMAN EMBRYONIC STEM CELLS MARKET ANALYSIS

Human Embryonic Stem Cells Market, By Product (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, and Toxicology Testing) and By Geography (North America, Europe, Asia Pacific, and Rest of the World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Oct 2022
Code : CMI5275
Pages :170
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Human Embryonic Stem Cells Market: Key Developments

In July 2020, Thermo Fisher Scientific Inc. and QIAGEN N.V. entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN.

In January 2020, Astellas Pharma Inc. and Adaptimmune Therapeutics Plc. entered into a co-development and co-commercialization agreement to bring new stem-cell derived allogeneic T-cell therapies to people with cancer.